- Home
- LNTH vs AB Comparison
LNTH vs AB Comparison
Compare LNTH & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- AB
- Stock Information
- Founded
- LNTH 1956
- AB 1987
- Country
- LNTH United States
- AB United States
- Employees
- LNTH 808
- AB N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AB Investment Managers
- Sector
- LNTH Health Care
- AB Finance
- Exchange
- LNTH Nasdaq
- AB Nasdaq
- Market Cap
- LNTH 3.8B
- AB 4.5B
- IPO Year
- LNTH 2015
- AB 1988
- Fundamental
- Price
- LNTH $56.28
- AB $39.87
- Analyst Decision
- LNTH Buy
- AB Hold
- Analyst Count
- LNTH 6
- AB 5
- Target Price
- LNTH $74.50
- AB $41.00
- AVG Volume (30 Days)
- LNTH 1.5M
- AB 152.4K
- Earning Date
- LNTH 11-06-2025
- AB 10-23-2025
- Dividend Yield
- LNTH N/A
- AB 8.23%
- EPS Growth
- LNTH N/A
- AB N/A
- EPS
- LNTH 3.77
- AB 3.03
- Revenue
- LNTH $1,520,653,000.00
- AB N/A
- Revenue This Year
- LNTH N/A
- AB N/A
- Revenue Next Year
- LNTH $2.25
- AB $7.56
- P/E Ratio
- LNTH $14.86
- AB $13.05
- Revenue Growth
- LNTH 5.75
- AB N/A
- 52 Week Low
- LNTH $47.25
- AB $32.28
- 52 Week High
- LNTH $118.21
- AB $43.30
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- AB 58.81
- Support Level
- LNTH $56.03
- AB $39.01
- Resistance Level
- LNTH $57.94
- AB $40.20
- Average True Range (ATR)
- LNTH 1.56
- AB 0.62
- MACD
- LNTH 0.39
- AB 0.11
- Stochastic Oscillator
- LNTH 79.58
- AB 84.76
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (41% of assets under management), retail (42%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of June 2025, the company had $829 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (41%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.